Riskpilot← Back to searchSign inGet full accessAB Alldoc
ABActiveOrg 5590468830Dvärsättsvägen 2General medical practice activities · NACE 8621Est. 20161 employees
Revenue 2024
SEK 156K
+105% vs 2023
EBITDA margin
64.7%
+181% vs 2023
Equity ratio
99.6%
Financial strength
Net profit 2024
SEK 82K
+183% vs 2023
| Revenue | SEK 156K | +105% |
| EBITDA | SEK 101K | +181% |
| Net profit | SEK 82K | +183% |
| Total assets | SEK 841K | +1% |
| Equity | SEK 838K | -11% |
| Employees | 1 | — |
Legal name
AB Alldoc
Org number
5590468830
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
13 januari 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet inom allmänmedicin, folkhälsa, ledarskap och organisation, företrädesvis i rollen som läkare. Uthyrning av sjukvårdspersonal. Kursverksamhet inom sjukvård, friskvård, friluftsliv, ledarskap, handledning, konsultation, organisation samt hantverk tex slöjd, textil. Forskning och innovationsverksamhet. Produktutveckling inom sjukvård, medicin, sport- och friluftsliv, IT och hantverk. Eventverksamhet, fastighetsförvaltning, handel med värdepapper.
Address
Dvärsättsvägen 2
Email
viveka.norlund-elmroth@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 45 | 636 | 459 | 76 | 156 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −3 | 586 | 400 | 36 | 101 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −3 | 586 | 400 | 36 | 101 |
| Net financials | −1 | — | −1 | 1 | 3 |
| Profit before tax | −5 | 587 | 400 | 36 | 103 |
| Tax | −0 | −121 | −84 | −7 | −21 |
| Net profit | −5 | 466 | 316 | 29 | 82 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 689 | 968 | 1 100 | 829 | 841 |
| Equity | 702 | 968 | 1 100 | 943 | 838 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 13 | 0 | 0 | 114 | 3 |
| Total debt | 13 | — | — | 114 | 3 |
EBITDA margin
64.7%
This company
15.8%
Market median
+309% vs market
20202024
Equity ratio
99.6%
This company
38.2%
Market median
+161% vs market
20202024
Return on equity
9.8%
This company
18.4%
Market median
-47% vs market
20202024
Net profit margin
52.6%
This company
8.1%
Market median
+549% vs market
20202024
Asset turnover
0.19×
This company
1.12×
Market median
-83% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SV Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AB Alldoc also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Susanne Viveka Norlund Elmroth | Chief Executive Officer | 0 companies |
| Charlotta Anna Eivor Leijon | Deputy Board Member | 0 companies |
| Viveka Sofia Viktoria Elmroth | Deputy Board Member | 0 companies |
| Jan-Erik Ivert Elmroth | Deputy Board Member | 0 companies |